News from Globe And Mail Investing
What is your interest today?
Tariffs
Stocks
Investors
Markets
Investor
Economy
Canadian
Trade
Upgrades
Downgrades
Bank Of Canada
Investment
Trade War
Tsx
Equities
Stock
Earnings
Investing
Dividend
Ceo
Bmo
Real Estate
Us
Inflation
Economists
Mortgage
Gold
China
Wall Street
Sector
Investments
Interest Rates
Sp 500
Mortgage Rates
Oil
Yields
Shares
Stock Futures
Company
Policy
Transactions
Insider Report
Trump
Finance
Recession
Corporate
Portfolio
Strategist
Dividends
Economist
Bce
Intellectual Property
Bond Investors
Suncor
Iif
Product Shelves
Campaign Promises
Position
Variable Rate Mortgages
Analyst Sentiment
= 1024) { setSearchBy('title'); suggestionOpen = true; fetch() }"
@input.debounce.300ms="window.innerWidth >= 1024 && fetch()"
@keydown.enter.prevent="window.innerWidth >= 1024 && submitSearch()"
placeholder="Search Globe And Mail Investing headlines…"
class="flex-grow bg-transparent border-0 focus:ring-0 px-4 py-2 placeholder-gray-500 dark:placeholder-gray-400 text-gray-900 dark:text-gray-100 mr-2"
/>
Globe and Mail Investing • Jun 10, 2025
Vaccine stocks muted as investors assess Kennedy’s overhaul of key panel
Investors are cautiously evaluating potential changes to regulatory oversight, which may impact vaccine companies' market performance, while awaiting further clarity from the upcom...
Read Full Article →